← Back to headlines
Corcept Therapeutics and Avnet Receive Stock Upgrades
Corcept Therapeutics saw its stock climb following an upgrade from UBS, while Avnet also rose after a rating upgrade from BofA.
13 May, 15:37 — 13 May, 15:37
Sources
Showing 1 of 1 sources
